Borosil Scientific Ltd (BOROSCI) — shareholding pattern, promoter holding, financials and share price

About Borosil Scientific Ltd (BOROSCI)

Borosil Scientific Ltd operates in the Glass - Industrial industry, within the Capital Goods sector. It trades on the NSE as BOROSCI and on the BSE under scrip code 544184. Its ISIN is INE02L001032.

Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology. [1]

Borosil Scientific Limited manufactures laboratory glassware, laboratory instruments, process systems and pharmaceutical primary packaging (ampoules and vials), operating four manufacturing locations in India, offering over 4,000 SKUs and exporting to 90+ countries under brands such as BOROSIL, LabQuest and Borosil Process Sciences, serving pharmaceuticals, research institutions, academia and industrial laboratories.

Q3FY26 consolidated revenue was Rs.121.3 crore (up 19.6% YoY) with consolidated EBITDA at Rs.19.6 crore (16.2% margin) and consolidated PAT of Rs.8.7 crore, reflecting quarter‑level operating leverage; nine‑month consolidated results were muted due to lower Process Systems execution and exceptional items related to restructuring and labour code adjustments.

Listed peers in Glass - Industrial: Mold-Tek Packaging Ltd, Electrotherm (India) Ltd, Mahamaya Steel Industries Ltd, Aeroflex Enterprises Ltd, Manaksia Coated Metals & Industries Ltd, Roto Pumps Ltd.

Valuation & Returns

10 Jul 2026

At ₹157 a share on 10 Jul 2026, Borosil Scientific Ltd (BOROSCI) was valued at a price-to-earnings ratio of 40.37x against an industry P/E of 37x and a price-to-book of 3.45x on a book value of ₹45.46 per share as of Mar 2025. Solomo computes return on equity of 8.55% and return on capital employed of 10.5% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
40.37x
Industry P/E
37x
P/B
3.45x
EPS (TTM)
₹3.89
Book value / share
₹45.46
ROE
8.55%
ROCE
10.5%
ROA
6.8%
Debt / equity
0.04x
Dividend yield
0%
EBITDA margin
13.53%
52-week range
₹96.65 – ₹190.45

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Borosil Scientific Ltd (BOROSCI) reported revenue of ₹467 crore, net profit of ₹35 crore and earnings per share of ₹3.89. That compares with revenue of ₹434 crore and net profit of ₹27 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹143 crore and net profit ₹27 crore (consolidated).

Consolidated annual results for Borosil Scientific Ltd (BOROSCI), Mar 2024 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2024Mar 2025Mar 2026
Revenue (₹ cr)392434467
Net profit (₹ cr)232735
EPS (₹)2.653.013.89
Compound annual growth for Borosil Scientific Ltd (BOROSCI). Stock price CAGR is price return and excludes dividends.
Measure5Y3Y1Y
Sales growth51.57%54.61%10.74%
Profit growth-59.88%13.80%
Stock price CAGR---2%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 68.27% of Borosil Scientific Ltd (BOROSCI) (up 0.19 pp QoQ), foreign institutional investors (FII) hold 0.23% and domestic institutional investors (DII) hold 0.27%. Market capitalisation was ₹1,396 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2024.

Largest disclosed public shareholders in Jun 2026: INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS 2.21%, BOROSIL SCIENTIFIC LIMITED UNCLAIMED SECURITIES SUSPENSE ESCROW ACCOUNT 2.17%, Unclaimed or Suspense or Escrow Account 2.17%, HUF 1.46%, DIPAK KANAYALAL SHAH 1.08%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202668.27%-0.23%0.27%31.73%
Mar 202668.08%-0.09%0.27%31.92%
Dec 202567.81%-0.07%0.19%32.19%
Sep 202567.81%-0.07%0.1%32.19%
Jun 202567.81%-0.21%0.05%32.19%
Mar 202567.82%-0.24%0.02%32.18%
Dec 202467.84%-0.26%0.02%32.16%
Sep 202467.87%-0.37%0.02%32.13%
Every quarter since Jun 2024 Filing data, not investment advice.